Shamez Ladhani to Neisseria meningitidis
This is a "connection" page, showing publications Shamez Ladhani has written about Neisseria meningitidis.
Connection Strength
2.541
-
Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England. Emerg Infect Dis. 2021 Sep; 27(9):2495-2497.
Score: 0.773
-
Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017). BMC Infect Dis. 2019 Jun 14; 19(1):522.
Score: 0.671
-
Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015-2016. Emerg Infect Dis. 2017 07; 23(7):1184-1187.
Score: 0.588
-
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents. BMJ Open. 2018 07 10; 8(7):e020988.
Score: 0.157
-
Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015. Vaccine. 2018 06 18; 36(26):3876-3881.
Score: 0.155
-
Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017 10; 2(10):e473-e482.
Score: 0.148
-
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021 06; 3(6):e360-e370.
Score: 0.048